Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 1193

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 1193
---
Amendment | ​ | ​ | PreviouslyFiled | ​ |
| 10.3*         | ​ | ​ | License Agreement dated April 4, 2013 by and between the Registrant and Maruishi Pharmaceutical Co., Ltd.                                       | ​ | ​ | S-1                       | ​ | ​ | 11/08/2013 | ​ | ​ |   10.7 | ​ | ​ | ​             | ​ | ​ | ​                      | ​ | ​ | ​               | ​ |
| 10.4*         | ​ | ​ | License and API Supply Agreement effective as of April 16, 2012 by and between the Registrant and Chong Kun Dang Pharmaceutical Corp.           | ​ | ​ | S-1                       | ​ | ​ | 11/08/2013 | ​ | ​ |   10.8 | ​ | ​ | ​             | ​ | ​ | ​                      | ​ | ​ | ​               | ​ |
| 10.5          | ​ | ​ | Amendment to License and API Supply Agreement effective as of May 1, 2012 by and between the Registrant and Chong Kun Dang Pharmaceutical Corp. | ​ | ​ | S-1                       | ​ | ​ | 11/08/2013 | ​ | ​ |   10.9 | ​ | ​ | ​             | ​ | ​ | ​                      | ​ | ​ | ​               | ​ |
| 10.6†         | ​ | ​ | API Commercial Supply Agreement between Cara Therapeutics, Inc. and Polypeptide Laboratories S.A.                                               | ​ | ​ | 10-Q                      | ​ | ​ | 11/08/2021 | ​ | ​ |   10.1 | ​ | ​ | ​             | ​ | ​ | ​                      | ​ | ​ | ​               | ​ |
| 10.7

#         | ​ | ​ | Employment Agreement with Christopher Posner                                                                                                    | ​ | ​ | 8-K                       | ​ | ​ | 11/03/2021 | ​ | ​ |   10.1 | ​ | ​ | ​             | ​ | ​ | ​                      | ​ | ​ | ​               | ​ |
| 10.8

#         | ​ | ​ | Offer Letter with Ryan Maynard                                                                                                                  | ​ | ​ | 8-K                       | ​ | ​ | 09/12/2022 | ​ | ​ |